Swift Biosciences is a company developing technologies to enable genomics and personalized medicine. The company's technology allows healthcare professionals and researchers to examine disease-related genes, and are designed to help computers analyze samples faster, easier, and with greater sensitivity and accuracy, all while being compatible with existing instrumentation.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/18/13 | $7,000,000 | Series B |
Charter Capital Partners Fletcher Spaght Ventures Mercury Fund Renaissance Venture Capital Fund | undisclosed |
